D. Stevens

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report

K. Vermaelen, V. Surmont, Lander Acker, 2021, Journal of Medical Case Reports.

Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.

D. Taub, D. Longo, W. Alvord, 1999, Clinical immunology.

Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.

D. Longo, W. Alvord, J. Janik, 2000, The cancer journal from Scientific American.

Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin.

L L Miller, E L Korn, E. Korn, 1999, Blood.

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma.

E. Korn, D. Longo, M. Sznol, 2001, Blood.

Dendritic Cell-Based Immunotherapy in Lung Cancer

B. Vandekerckhove, K. Vermaelen, S. Van Lint, 2021, Frontiers in Immunology.